C.C.M. Bartels

1.3k total citations
20 papers, 943 citations indexed

About

C.C.M. Bartels is a scholar working on Genetics, Oncology and Cancer Research. According to data from OpenAlex, C.C.M. Bartels has authored 20 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 7 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in C.C.M. Bartels's work include BRCA gene mutations in cancer (16 papers), Global Cancer Incidence and Screening (4 papers) and Cancer Genomics and Diagnostics (4 papers). C.C.M. Bartels is often cited by papers focused on BRCA gene mutations in cancer (16 papers), Global Cancer Incidence and Screening (4 papers) and Cancer Genomics and Diagnostics (4 papers). C.C.M. Bartels collaborates with scholars based in Netherlands, United States and Switzerland. C.C.M. Bartels's co-authors include Madeleine M.A. Tilanus‐Linthorst, Caroline Seynaeve, J.G.M. Klijn, Cecile T.M. Brekelmans, L.C. Verhoog, A.N. van Geel, E.J. Meijers-Heijboer, C. Crépin, Mieke Kriege and Hanne Meijers-Heijboer and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C.C.M. Bartels

19 papers receiving 907 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.C.M. Bartels Netherlands	10	723	378	301	243	198	20	943
Leon C. Verhoog Netherlands	8	860 1.2×	411 1.1×	337 1.1×	251 1.0×	209 1.1×	9	1.1k
L.C. Verhoog Netherlands	11	1.1k 1.5×	539 1.4×	296 1.0×	334 1.4×	285 1.4×	16	1.3k
Carina C. M. Bartels Netherlands	11	962 1.3×	401 1.1×	358 1.2×	221 0.9×	186 0.9×	11	1.2k
Bert van Geel Netherlands	7	756 1.0×	358 0.9×	254 0.8×	199 0.8×	160 0.8×	7	896
Kathleen R. Blazer United States	21	1.1k 1.5×	388 1.0×	359 1.2×	378 1.6×	376 1.9×	49	1.4k
Anna Felberg United States	13	439 0.6×	171 0.5×	209 0.7×	94 0.4×	231 1.2×	21	748
DF Easton United Kingdom	7	724 1.0×	291 0.8×	238 0.8×	283 1.2×	318 1.6×	16	940
Kerstin Rhiem Germany	15	572 0.8×	312 0.8×	184 0.6×	175 0.7×	258 1.3×	28	786
Joanne L. Johnson United States	10	1.2k 1.7×	850 2.2×	453 1.5×	329 1.4×	127 0.6×	12	1.6k
W. Ormiston Ireland	7	501 0.7×	138 0.4×	119 0.4×	127 0.5×	248 1.3×	10	629

Countries citing papers authored by C.C.M. Bartels

Since Specialization

Citations

This map shows the geographic impact of C.C.M. Bartels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.C.M. Bartels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.C.M. Bartels more than expected).

Fields of papers citing papers by C.C.M. Bartels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.C.M. Bartels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.C.M. Bartels. The network helps show where C.C.M. Bartels may publish in the future.

Co-authorship network of co-authors of C.C.M. Bartels

This figure shows the co-authorship network connecting the top 25 collaborators of C.C.M. Bartels. A scholar is included among the top collaborators of C.C.M. Bartels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.C.M. Bartels. C.C.M. Bartels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Heemskerk-Gerritsen, B.A.M., Maartje J. Hooning, Agnes Jager, et al.. (2010). 500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?. European Journal of Cancer Supplements. 8(3). 206–206. 8 indexed citations

2.

Dooren, S. van, Caroline Seynaeve, C.C.M. Bartels, et al.. (2007). Passive coping and psychological distress in women adhering to regular breast cancer surveillance. Psycho-Oncology. 16(9). 851–858. 34 indexed citations

3.

Brekelmans, Cecile T.M., Madeleine M.A. Tilanus‐Linthorst, Caroline Seynaeve, et al.. (2007). Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1/2 families as compared to sporadic breast cancer cases. European Journal of Cancer. 43(5). 867–876. 158 indexed citations

4.

Kriege, Mieke, Cecile T.M. Brekelmans, Hans Peterse, et al.. (2006). Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Research and Treatment. 102(3). 357–363. 27 indexed citations

5.

Dooren, S. van, C. Seynaeve, C.C.M. Bartels, et al.. (2006). The psychological impact of regular surveillance in women at increased risk for hereditary breast cancer. European Journal of Cancer Supplements. 4(2). 88–89. 1 indexed citations

6.

Brekelmans, Cecile T.M., Caroline Seynaeve, M. Menke-Pluymers, et al.. (2005). Survival and prognostic factors in BRCA1-associated breast cancer. Annals of Oncology. 17(3). 391–400. 101 indexed citations

7.

Rijnsburger, Adriana J., Marie‐Louise Essink‐Bot, S. van Dooren, et al.. (2004). Impact of screening for breast cancer in high-risk women on health-related quality of life. British Journal of Cancer. 91(1). 69–76. 60 indexed citations

8.

Klijn, J.G.M., A.N. van Geel, Hanne Meijers-Heijboer, et al.. (2004). Long-term follow-up of the Rotterdam study on prophylactic mastectomy versus surveillance in BRCA1/2 mutation carriers. Journal of Clinical Oncology. 22(14_suppl). 9502–9502. 2 indexed citations

9.

Klijn, J.G.M., A.N. van Geel, Hanne Meijers-Heijboer, et al.. (2004). Long-term follow-up of the Rotterdam study on prophylactic mastectomy versus surveillance in BRCA1/2 mutation carriers. Journal of Clinical Oncology. 22(14_suppl). 9502–9502. 7 indexed citations

10.

Dooren, S. van, Adriana J. Rijnsburger, Caroline Seynaeve, et al.. (2003). Psychological Distress and Breast Self-Examination Frequency in Women at Increased Risk for Hereditary or Familial Breast Cancer. Public Health Genomics. 6(4). 235–241. 27 indexed citations

11.

Verhoog, L.C., A.M.W. van den Ouweland, E. Berns, et al.. (2001). Large regional differences in the frequency of distinct BRCA1/BRCA2 mutations in 517 Dutch breast and/or ovarian cancer families. European Journal of Cancer. 37(16). 2082–2090. 52 indexed citations

12.

Brekelmans, Cecile T.M., Caroline Seynaeve, C.C.M. Bartels, et al.. (2001). Effectiveness of Breast Cancer Surveillance in BRCA1/2 Gene Mutation Carriers and Women With High Familial Risk. Journal of Clinical Oncology. 19(4). 924–930. 233 indexed citations

13.

Tilanus‐Linthorst, Madeleine M.A., et al.. (2000). Earlier detection of breast cancer by surveillance of women at familial risk. European Journal of Cancer. 36(4). 514–519. 70 indexed citations

14.

Brekelmans, Cecile T.M., C.C.M. Bartels, Ellen Crepin, et al.. (1999). Screening women with a family history of breast cancer. European Journal of Cancer. 35. S158–S158. 2 indexed citations

15.

Verhoog, L.C., Cecile T.M. Brekelmans, Caroline Seynaeve, et al.. (1999). Survival in Hereditary Breast Cancer Associated With Germline Mutations of BRCA2. Journal of Clinical Oncology. 17(11). 3396–3402. 135 indexed citations

16.

Verhoog, L.C., Cecile T.M. Brekelmans, C. Seynaeve, et al.. (1998). Survival and Tumour Characteristics of Breast-Cancer Patients with Germline Mutations of BRCA1. Obstetrical & Gynecological Survey. 53(6). 354–355. 9 indexed citations

17.

Egger, Bernhard, Christoph A. Maurer, C.C.M. Bartels, & Hans U. Baer. (1997). Primary Carcinoma of the Gallbladder: ‘A Swiss Center’s Experience’. Digestive Surgery. 14(3). 169–174. 5 indexed citations

18.

Bartels, C.C.M., et al.. (1995). [Good results in periodic screening in women with increased risk of breast cancer; retrospective study].. PubMed. 139(9). 445–9. 4 indexed citations

19.

Bontenbal, M., A.S.T. Planting, C. J. Rodenburg, et al.. (1992). Weekly low-dose mitoxantrone plus doxorubicin as second-line chemotherapy for advanced breast cancer. Breast Cancer Research and Treatment. 21(2). 133–138. 5 indexed citations

20.

Bartels, C.C.M., et al.. (1985). Mastitis and toxic shock syndrome (tampon disease).. PubMed. 37(4). 101–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact